bioRxiv · 10.1101/180943
Inhibition of p53 improves CRISPR/Cas-mediated precision genome editing
Abstract
We report here that genome editing by CRISPR/Cas9 induces a p53-mediated DNA damage response and cell cycle arrest. Transient inhibition of p53 prevents this response, and increases the rate of homologous recombination more than five-fold. This provides a way to improve precision genome editing of normal cells, but warrants caution in using CRISPR for human therapies until the mechanism of the activation of p53 is elucidated.
Source connections
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Haapaniemi, E., Botla, S. K., Persson, J., Schmierer, B., Taipale, J.. 2017-08-25. Inhibition of p53 improves CRISPR/Cas-mediated precision genome editing. https://doi.org/10.1101/180943
Cite the original work for its findings. Save a collection to share your selection of sources.